Douglas Friedman

BioMADE

Doug-Friedman_200x250.jpg

Douglas Friedman is CEO of BioMADE, the Bioindustrial Manufacturing Innovation Institute. In founding BioMADE, Doug seeks to secure the growth of the U.S. industrial biomanufacturing ecosystem and advance the bioeconomy. He is also President of the Engineering Biology Research Consortium (EBRC), a nonprofit membership organization focused on advancing precompetitive technologies in a safe, secure, sustainable, and ethical manner. At EBRC, Doug focuses on strategic initiatives, serves on the board and key leadership groups, and mentors science policy postdoctoral fellows. He was the inaugural Executive Director of EBRC from 2016 to 2021.  

His primary scientific and technical interests lie in the fields of synthetic biology, biomanufacturing, and modern biotechnology. Doug's policy interests include development of sustainable biotechnology, safeguarding the bioeconomy, and accelerating technical advancement by building diverse, robust community partnerships. He regularly serves as a subject matter expert on emerging biotechnologies, biotechnology policy, and national security topics at the interface of the biological and chemical sciences. Doug participates in more than a dozen external scientific and policy committees and boards.  

Prior to his role at EBRC, Doug was a study director and senior program officer with the Board on Chemical Sciences and Technology at the National Academies of Sciences, Engineering, and Medicine. His primary portfolio focused on the advancement of science and engineering at the interface of chemistry and biology, often as they related to national security.  

Earlier in his career, Doug performed research in physical organic chemistry and chemical biology in academia and industry. He earned a Ph.D. in Chemistry from Northwestern University and a B.S. in Chemical Biology from the University of California, Berkeley.  

KEYNOTE

Tuesday, May 31, 2022 at 8:45am

Engineering Biology to Biomanufactuing: A Journey of Growth and Impact

Engineering and synthetic biology have the opportunity to transform the world we live in. To effectively maximize the opportunity and realize an engineering biology-enabled future, communities must come together around a strategic vision for sustainable growth and development. This talk will provide an overview of experiences community building to establish an ecosystem that allows for effective research, development, and commercialization stemming from modern biotechnology. Doug will provide an overview of experiences with the development of the Engineering Biology Research Consortium and BioMADE, and bring forward key points of discussion about how to effectively build a national strategy from the ground up.